Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J’s blockbuster hopeful erdafitinib gets ‘breakthrough’ moniker
J&J’s blockbuster hopeful erdafitinib gets ‘breakthrough’ moniker
J&J’s blockbuster hopeful erdafitinib gets ‘breakthrough’ moniker
Submitted by
admin
on March 15, 2018 - 9:56am
Source:
Endpoints
News Tags:
JNJ
erdafitinib
breakthrough therapies
metastatic urothelial cancer
Headline:
J&J’s blockbuster hopeful erdafitinib gets ‘breakthrough’ moniker
Do Not Allow Advertisers to Use My Personal information
